The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Epidemiology and Prevention of Prostate Cancer
Abstract
CONTEXT Worldwide, prostate cancer (PCa) represents the second most common solid tumor in men. OBJECTIVE To assess the geographical distribution of PCa, epidemiological differences, and the most relevant risk factors for the disease. EVIDENCE ACQUISITION Estimated incidence, mortality, and prevalence of PCa for the year 2020 in 185 countries were derived from the IARC GLOBOCAN database. A review of English-language articles published between 2010 and 2020 was conducted using MEDLINE, EMBASE, and Scopus to identify risk factors for PCa. EVIDENCE SYNTHESIS In the year 2020, there were over 1414000 estimated new cases of PCa worldwide, with an age-standardized rate (ASR) incidence of 31 per 100000 (lifetime cumulative risk: 3.9%). Northern Europe has the highest all-age incidence ASR (83), while the lowest ASR was in South-Central Asia (6.3). In the year 2020, there were over 375000 estimated deaths worldwide, and the overall mortality ASR was 7.7 per 100000, with the highest ASR in the Caribbean (28) and the lowest in South-Central Asia (3.1). Family history, hereditary syndromes, and race are the strongest risk factors for PCa. Metabolic syndrome was associated with the risk of developing PCa, high-grade disease, and adverse pathology. Diabetes and exposure to ultraviolet rays were found to be inversely associated to PCa incidence. Cigarette smoking and obesity may increase PCa-specific mortality, while regular physical activity may reduce disease progression. Although 5-alpha reductase inhibitors are known to be associated with a reduced incidence of PCa, available studies failed to show an effect on overall mortality. CONCLUSIONS Family history, race, and hereditary syndromes are well-established risk factors for PCa. Modifiable risk factors may impact the risk of developing PCa and that of dying from the disease, but little evidence exist for any clear indication for prevention other than early diagnosis to reduce PCa mortality. PATIENT SUMMARY Prostate cancer (PCa) rates vary profoundly worldwide, with incidence and mortality rates being highest in Northern Europe and Caribbean, respectively. South-Central Asia has the lowest epidemiological burden. Family history, race, and hereditary syndromes are well-established risk factors for PCa. Modifiable risk factors may impact the risk of developing PCa and that of dying from the disease itself, but little evidence exist for any clear indication for prevention other than early diagnosis to reduce PCa mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationCancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Cancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,689
Self-citation(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Mottet, N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.042 · Cited by 2,802
Self-citationEpidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,518
Sathianathen, N. (2021) · 50 Studies Every Urologist Should Know · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,080
Klein, E. A., Thompson, I. M., Tangen, C. M., Crowley, J. J., Lucia, M. S., Goodman, P. J., Minasian, L. M., Ford, L. G., Parnes, H. L., Gaziano, J. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1437 · Cited by 1,787
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Gordon, D., Copeland, T., D’Agostino, D., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1809944 · Cited by 1,615
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F., & Jemal, A. (2020) · European Urology · doi:10.1016/j.eururo.2019.08.005 · Cited by 1,364
Self-citationUnited Nations Statistics Division
(2006) · Choice Reviews Online · doi:10.5860/choice.43sup-0473 · Cited by 1,202
Effect of Dutasteride on the Risk of Prostate Cancer
Andriole, G. L., Bostwick, D. G., Brawley, O. W., Gomella, L. G., Marberger, M., Montorsi, F., Pettaway, C. A., Tammela, T. L., Teloken, C., Tindall, D. J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908127 · Cited by 1,152
Heinonen, O. P., Koss, L., Albanes, D., Taylor, P. R., Hartman, A. M., Edwards, B. K., Virtamo, J., Huttunen, J. K., Haapakoski, J., Malila, N., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.6.440 · Cited by 918
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
Hugosson, J., Roobol, M. J., Månsson, M., Tammela, T. L. J., Zappa, M., Nelen, V., Kwiatkowski, M., Lujan, M., Carlsson, S. V., Talala, K. M., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.02.009 · Cited by 698
Dominguez-Valentin, M., Sampson, J. R., Seppälä, T. T., ten Broeke, S. W., Plazzer, J.-P., Nakken, S., Engel, C., Aretz, S., Jenkins, M. A., Sunde, L., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-019-0596-9 · Cited by 662
Hereditary Prostate Cancer: Epidemiologic and Clinical Features
Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., & Walsh, P. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35617-3 · Cited by 612
Welch, H. G., & Albertsen, P. C. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp278 · Cited by 575
Duffield‐Lillico, A. J., Dalkin, B. L., Reid, M. E., Turnbull, B. W., Slate, E. H., Jacobs, E. T., Marshall, J. R., Clark, L. C., & for the Nutritional Prevention of Cancer Study Group (2003) · BJU International · doi:10.1046/j.1464-410x.2003.04167.x · Cited by 514
Conti, D. V., Darst, B. F., Moss, L. C., Saunders, E. J., Sheng, X., Chou, A., Schumacher, F. R., Olama, A. A. A., Benlloch, S., Dadaev, T., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00748-0 · Cited by 462
Self-citationTuohimaa, P., Tenkanen, L., Ahonen, M., Lumme, S., Jellum, E., Hallmans, G., Stattin, P., Harvei, S., Hakulinen, T., Luostarinen, T., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.11375 · Cited by 428
Self-citationCafestol and Kahweol, Two Coffee Specific Diterpenes with Anticarcinogenic Activity
Cavin, C., Holzhaeuser, D., Scharf, G., Constable, A., Huber, W. W., & Schilter, B. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00029-7 · Cited by 422
Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality
Dess, R. T., Hartman, H. E., Mahal, B. A., Soni, P. D., Jackson, W. C., Cooperberg, M. R., Amling, C. L., Aronson, W. J., Kane, C. J., Terris, M. K., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0826 · Cited by 414
Self-citationEpidemiology of prostate cancer in Asian countries
Kimura, T., & Egawa, S. (2018) · International Journal of Urology · doi:10.1111/iju.13593 · Cited by 411
Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer
Bañez, L. L., Hamilton, R. J., Partin, A. W., Vollmer, R. T., Sun, L., Rodriguez, C., Wang, Y., Terris, M. K., Aronson, W. J., Presti, J. C., et al. (2007) · JAMA · doi:10.1001/jama.298.19.2275 · Cited by 357
Self-citationAn updated systematic review and meta-analysis on adherence to mediterranean diet and risk of cancer
Morze, J., Danielewicz, A., Przybyłowicz, K., Zeng, H., Hoffmann, G., & Schwingshackl, L. (2021) · European Journal of Nutrition · doi:10.1007/s00394-020-02346-6 · Cited by 352
Long-Term Survival of Participants in the Prostate Cancer Prevention Trial
Thompson, I. M., Goodman, P. J., Tangen, C. M., Parnes, H. L., Minasian, L. M., Godley, P. A., Lucia, M. S., & Ford, L. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215932 · Cited by 288
Epidemiology and genomics of prostate cancer in Asian men
Zhu, Y., Mo, M., Wei, Y., Wu, J., Pan, J., Freedland, S. J., Zheng, Y., & Ye, D. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00442-8 · Cited by 287
Self-citationProstate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study
Nyberg, T., Frost, D., Barrowdale, D., Evans, D. G., Bancroft, E., Adlard, J., Ahmed, M., Barwell, J., Brady, A. F., Brewer, C., et al. (2020) · European Urology · doi:10.1016/j.eururo.2019.08.025 · Cited by 248
Page, E. C., Bancroft, E. K., Brook, M. N., Assel, M., Hassan Al Battat, M., Thomas, S., Taylor, N., Chamberlain, A., Pope, J., Raghallaigh, H. N., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.08.019 · Cited by 247
Sartore-Bianchi, A., Ardini, E., Bosotti, R., Amatu, A., Valtorta, E., Somaschini, A., Raddrizzani, L., Palmeri, L., Banfi, P., Bonazzina, E., et al. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv306 · Cited by 245
Ling, S., Brown, K., Miksza, J. K., Howells, L., Morrison, A., Issa, E., Yates, T., Khunti, K., Davies, M. J., & Zaccardi, F. (2020) · Diabetes Care · doi:10.2337/dc20-0204 · Cited by 241
Islami, F., Moreira, D. M., Boffetta, P., & Freedland, S. J. (2014) · European Urology · doi:10.1016/j.eururo.2014.08.059 · Cited by 225
Self-citationSeparate and unequal: residential segregation and black health disparities.
Landrine, H., & Corral, I. (2009) · PubMed · Cited by 219
A Prospective Study of Meat and Meat Mutagens and Prostate Cancer Risk
Cross, A. J., Peters, U., Kirsh, V. A., Andriole, G. L., Reding, D., Hayes, R. B., & Sinha, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2191 · Cited by 196
Watkins Bruner, D., Moore, D., Parlanti, A., Dorgan, J., & Engstrom, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11466 · Cited by 190
Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis
Applegate, C., Rowles, J., Ranard, K., Jeon, S., & Erdman, J. (2018) · Nutrients · doi:10.3390/nu10010040 · Cited by 176
European cancer mortality predictions for the year 2020 with a focus on prostate cancer
Carioli, G., Bertuccio, P., Boffetta, P., Levi, F., La Vecchia, C., Negri, E., & Malvezzi, M. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.009 · Cited by 171
Self-citationWang, Y., Cui, R., Xiao, Y., Fang, J., & Xu, Q. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137427 · Cited by 170
Meta-analysis of metabolic syndrome and prostate cancer
Gacci, M., Russo, G. I., De Nunzio, C., Sebastianelli, A., Salvi, M., Vignozzi, L., Tubaro, A., Morgia, G., & Serni, S. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2017.1 · Cited by 167
Han, M. A., Zeraatkar, D., Guyatt, G. H., Vernooij, R. W. M., El Dib, R., Zhang, Y., Algarni, A., Leung, G., Storman, D., Valli, C., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0699 · Cited by 163
Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta–analysis
Zhao, J., Stockwell, T., Roemer, A., & Chikritzhs, T. (2016) · BMC Cancer · doi:10.1186/s12885-016-2891-z · Cited by 160
Rowles, J. L., Ranard, K. M., Smith, J. W., An, R., & Erdman, J. W. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2017.25 · Cited by 160
Ejaculation Frequency and Subsequent Risk of Prostate Cancer
Leitzmann, M. F., Platz, E. A., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (2004) · JAMA · doi:10.1001/jama.291.13.1578 · Cited by 155
Michels, N., van Aart, C., Morisse, J., Mullee, A., & Huybrechts, I. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103177 · Cited by 154
Boyle, P., Koechlin, A., Bota, M., d’Onofrio, A., Zaridze, D. G., Perrin, P., Fitzpatrick, J. M., Burnett, A. L. “., & Boniol, M. (2016) · British Journal of Urology · doi:10.1111/bju.13417 · Cited by 146
Rider, J. R., Wilson, K. M., Sinnott, J. A., Kelly, R. S., Mucci, L. A., & Giovannucci, E. L. (2016) · European Urology · doi:10.1016/j.eururo.2016.03.027 · Cited by 146
Metformin Use and Prostate Cancer Risk
Preston, M. A., Riis, A. H., Ehrenstein, V., Breau, R. H., Batista, J. L., Olumi, A. F., Mucci, L. A., Adami, H., & Sørensen, H. T. (2014) · European Urology · doi:10.1016/j.eururo.2014.04.027 · Cited by 145
Familial risk and familial survival in prostate cancer
Hemminki, K. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0801-1 · Cited by 144
Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence
Dasgupta, P., Baade, P. D., Aitken, J. F., Ralph, N., Chambers, S. K., & Dunn, J. C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00238 · Cited by 140
Prostate Cancer Susceptibility in Men of African Ancestry at 8q24
Han, Y., Rand, K. A., Hazelett, D. J., Ingles, S. A., Kittles, R. A., Strom, S. S., Rybicki, B. A., Nemesure, B. B., Isaacs, W. B., Stanford, J. L., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv431 · Cited by 134
Haider, A., Zitzmann, M., Doros, G. D., Isbarn, H., Hammerer, P., & Yassin, A. A. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.06.071 · Cited by 125
Prospective study of ultraviolet radiation exposure and risk of cancer in the United States
Lin, S., Wheeler, D. C., Park, Y., Cahoon, E. K., Hollenbeck, A. R., Freedman, D. M., & Abnet, C. C. (2012) · International Journal of Cancer · doi:10.1002/ijc.27619 · Cited by 123
Brookman-May, S. D., Campi, R., Subiela, J. D., Klatte, T., Langenhuijsen, J. F., Brausi, M. A., Linares-Espinós, E., Volpe, A., Marszalek, M., Akdoğan, B., et al. (2018) · European Urology Focus · doi:10.1016/j.euf.2018.02.007 · Cited by 122
Gandaglia, G., Albers, P., Abrahamsson, P.-A., Briganti, A., Catto, J. W. F., Chapple, C. R., Montorsi, F., Mottet, N., Roobol, M. J., Sønksen, J., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.04.033 · Cited by 122
Self-citationTestosterone Therapy in Men With Prostate Cancer
Kaplan, A. L., Hu, J. C., Morgentaler, A., Mulhall, J. P., Schulman, C. C., & Montorsi, F. (2015) · European Urology · doi:10.1016/j.eururo.2015.12.005 · Cited by 120
Occupational Risk Factors for Prostate Cancer: A Meta-analysis
Krstev, S., & Knutsson, A. (2019) · Journal of Cancer Prevention · doi:10.15430/jcp.2019.24.2.91 · Cited by 104
Hypertension and risk of prostate cancer: a systematic review and meta-analysis
Liang, Z. C., Xie, B., Li, J., Wang, X., Wang, S., Meng, S., Ji, A., Zhu, Y., Xu, X., Zheng, X., et al. (2016) · Scientific Reports · doi:10.1038/srep31358 · Cited by 102
Ola Bratt, A., Drevin, L., Akre, O., Garmo, H., & Stattin, P. E. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw110 · Cited by 100
Self-citationHarrison, S., Tilling, K. M., Turner, E. L., Martin, R. M., Lennon, R. J., Lane, J. A., Donovan, J., Hamdy, F. C., Neal, D. E., Bosch, J. L. H. R., et al. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01291-3 · Cited by 100
Seraphin, T. P., Joko-Fru, W. Y., Kamaté, B., Chokunonga, E., Wabinga, H., Somdyala, N. I. M., Manraj, S. S., Ogunbiyi, O. J., Dzamalala, C. P., Finesse, A., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1005 · Cited by 97
Impact of obesity upon prostate cancer-associated mortality: A meta-analysis of 17 cohort studies
ZHANG, X., ZHOU, G., SUN, B., ZHAO, G., LIU, D., SUN, J., LIU, C., & GUO, H. (2015) · Oncology Letters · doi:10.3892/ol.2014.2841 · Cited by 91
Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry
Conti, D. V., Wang, K., Sheng, X., Bensen, J. T., Hazelett, D. J., Cook, M. B., Ingles, S. A., Kittles, R. A., Strom, S. S., Rybicki, B. A., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx084 · Cited by 89
Self-citationKelly, S. P., Graubard, B. I., Andreotti, G., Younes, N., Cleary, S. D., & Cook, M. B. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw225 · Cited by 85
Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis
Benke, I. N., Leitzmann, M. F., Behrens, G., & Schmid, D. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy073 · Cited by 84
Llaha, F., Gil-Lespinard, M., Unal, P., de Villasante, I., Castañeda, J., & Zamora-Ros, R. (2021) · Nutrients · doi:10.3390/nu13020516 · Cited by 83
Associations of circulating 25‐hydroxyvitamin D with prostate cancer diagnosis, stage and grade
Gilbert, R., Metcalfe, C., Fraser, W. D., Donovan, J., Hamdy, F. C., Neal, D. E., Lane, J. A., & Martin, R. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.27327 · Cited by 83
Kensler, K., Pernar, C. H., Mahal, B., Nguyen, P., Trinh, Q., Kibel, A., & Rebbeck, T. (2020) · Journal of the National Cancer Institute · doi:10.1093/jnci/djaa171 · Cited by 82
Self-citationSong, J., Yuan, D., Rao, H., Chen, T.-F., Luan, B., Xu, X., Jiang, F., Zhong, W., & Zhu, J. (2016) · Medicine · doi:10.1097/md.0000000000002708 · Cited by 81
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence
Pierce, B. L. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.07.008 · Cited by 74
Disparities in prostate cancer incidence and mortality rates: Solvable or not?
Badal, S. A. M., Aiken, W. D., Morrison, B. F., Valentine, H., Bryan, S., Gachii, A., & Ragin, C. C. R. (2019) · The Prostate · doi:10.1002/pros.23923 · Cited by 74
Serum Prostate-Specific Antigen Levels in Men With Type 2 Diabetes
Fukui, M., Tanaka, M., Kadono, M., Imai, S., Hasegawa, G., Yoshikawa, T., & Nakamura, N. (2008) · Diabetes Care · doi:10.2337/dc07-1962 · Cited by 66
Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes
Beebe‐Dimmer, J., Kapron, A. L., Fraser, A. M., Smith, K. R., & Cooney, K. A. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02808 · Cited by 65
Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer
Plym, A., Penney, K. L., Kalia, S. S., Kraft, P., Conti, D. V., Haiman, C. A., Mucci, L. A., & Kibel, A. S. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab058 · Cited by 64
Self-citationBöehm, K., Sun, M., Larcher, A., Blanc-Lapierre, A., Schiffmann, J., Graefen, M., Sosa, J. F., Fred Saad, C., Parent, M., & Karakiewicz, P. I. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.07.006 · Cited by 63
Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis
Chen, X., Zhao, Y., Tao, Z., & Wang, K. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-038902 · Cited by 62
Smoking and Prostate Cancer: A Systematic Review
Nunzio, C. D., Andriole, G. L., Thompson, I. M., & Freedland, S. J. (2015) · European Urology Focus · doi:10.1016/j.euf.2014.10.002 · Cited by 61
Self-citationLong-term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer
Baillargeon, J., Kuo, Y., Fang, X., & Shahinian, V. B. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.05.099 · Cited by 60
Diabetes and prostate cancer risk in the REDUCE trial
Wu, C., Moreira, D. M., Gerber, L., Rittmaster, R. S., Andriole, G. L., & Freedland, S. J. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.28 · Cited by 59
Self-citationPlaza, B. L., Bermejo, L. M., Santurino, C., Cavero‐Redondo, I., Álvarez‐Bueno, C., & Gómez‐Candela, C. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz014 · Cited by 57
Human papillomavirus and risk of prostate cancer: a systematic review and meta-analysis
Russo, G. I., Calogero, A. E., Condorelli, R. A., Scalia, G., Morgia, G., & Vignera, S. L. (2018) · The Aging Male · doi:10.1080/13685538.2018.1455178 · Cited by 55
Liss, M. A., Al-Bayati, O., Gelfond, J., Goros, M. W., Ullevig, S. L., DiGiovanni, J., Hamilton‐Reeves, J. M., O’Keefe, D., Bacich, D. J., Weaver, B., et al. (2018) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-018-0105-2 · Cited by 54
Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms
Gulati, R., Cheng, H. H., Lange, P. H., Nelson, P. S., & Etzioni, R. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0434 · Cited by 53
Haring, A., Murtola, T. J., Talala, K. M., Taari, K., Tammela, T. L. J., & Auvinen, A. P. (2017) · Scandinavian Journal of Urology · doi:10.1080/21681805.2016.1271353 · Cited by 52
Fat Intake Is Not Linked to Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis
Xu, C., Han, F., Zeng, X., Liu, T.-Z., Shen, L., & Gao, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131747 · Cited by 49
Tonon, L., Fromont, G., Boyault, S., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.08.026 · Cited by 48
Hypogonadotropic Hypogonadism in Men with Type 2 Diabetes
Dandona, P., Dhindsa, S., Chandel, A., & Chaudhuri, A. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.05.2001 · Cited by 47
Sourbeer, K. N., Howard, L. E., Andriole, G. L., Moreira, D. M., Castro‐Santamaria, R., Freedland, S. J., & Vidal, A. C. (2014) · British Journal of Urology · doi:10.1111/bju.12843 · Cited by 47
Self-citationCampi, R., Brookman-May, S. D., Subiela, J. D., Akdoğan, B., Brausi, M. A., Klatte, T., Langenhuijsen, J. F., Linares-Espinós, E., Marszalek, M., Morgan Rouprêt, A., et al. (2018) · European Urology Focus · doi:10.1016/j.euf.2018.04.001 · Cited by 46
Homeobox B13 G84E Mutation and Prostate Cancer Risk
Nyberg, T., Govindasami, K., Leslie, G., Dadaev, T., Bancroft, E. K., Raghallaigh, H. N., Brook, M. N., Hussain, N., Keating, D., Lee, A., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.11.015 · Cited by 41
Shift Work and Prostate Cancer: An Updated Systematic Review and Meta-Analysis
Rivera‐Izquierdo, M., Martínez‐Ruiz, V., Castillo-Ruiz, E. M., Manzaneda-Navío, M., Pérez‐Gómez, B., & Jiménez‐Moleón, J. J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17041345 · Cited by 41
Alcohol Consumption and the Risk of Prostate Cancer: A Dose-Response Meta-Analysis
Hong, S., Khil, H., Lee, D. H., Keum, N., & Giovannucci, E. L. (2020) · Nutrients · doi:10.3390/nu12082188 · Cited by 37
The impact of moderate wine consumption on the risk of developing prostate cancer
Vartolomei, M. D., Kimura, S., Ferro, M., Foerster, B., Abufaraj, M. M., Briganti, A., Karakiewicz, P. I., & Shariat, S. F. (2018) · Clinical Epidemiology · doi:10.2147/clep.s163668 · Cited by 36
Wang, Y., Liu, X., Yan, P., Tang, J., Chen, T., Sun, Y., Zhou, W., Bi, Y., & Zhang, Z.-J. (2019) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000514 · Cited by 35
Dimitropoulou, P., Martin, R. M., Turner, E. L., Lane, J. A., Gilbert, R., Davis, M., Donovan, J., Hamdy, F. C., & Neal, D. E. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606066 · Cited by 33
Grill, S., Fallah, M., Leach, R. J., Thompson, I. M., Freedland, S. J., Hemminki, K., & Ankerst, D. P. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.09.018 · Cited by 33
Self-citationGonorrhea and Prostate Cancer Incidence: An Updated Meta-Analysis of 21 Epidemiologic Studies
Lian, W.-Q., Luo, F., Song, X., et al. (2015) · Medical Science Monitor · doi:10.12659/msm.893579 · Cited by 33
Mediterranean dietary pattern and the risk of prostate cancer
Cheng, S., Zheng, Q., Ding, G., & Li, G. (2019) · Medicine · doi:10.1097/md.0000000000016341 · Cited by 31
Prostate Cancer and Asbestos: A Systematic Review and Meta-Analysis
Dutheil, F., Zaragoza-Civale, L., Pereira, B., Mermillod, M., Baker, J. S., Schmidt, J., Moustafa, F., & Navel, V. (2020) · The Permanente Journal · doi:10.7812/tpp/19.086 · Cited by 21
Cited by
2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
Bergengren, O., Pekala, K. R., Matsoukas, K., Fainberg, J., Mungovan, S. F., Bratt, O., Bray, F., Brawley, O., Luckenbaugh, A. N., Mucci, L., et al. (2023) · European Urology · doi:10.1016/j.eururo.2023.04.021 · Cited by 848
Self-citationMostafavi, M., Ghazi, F., Mehrabifard, M., Alivirdiloo, V., Hajiabbasi, M., Rahimi, F., Mobed, A., Taheripak, G., Ramezani Farani, M., Huh, Y. S., et al. (2025) · Strahlentherapie und Onkologie · doi:10.1007/s00066-024-02301-y · Cited by 16
Metadata
- Authors
- Gandaglia, G., Leni, R., Bray, F., Fleshner, N., Freedland, S. J., Kibel, A., Stattin, P., Van Poppel, H., & La Vecchia, C.
- Venue
- European Urology Oncology
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 4
- Issue
- 6
- Pages
- 877-892
- ISSN
- 2588-9311 (ISSN-L)
- OpenAlex
- W3211281229
- Cited by
- 611
- References
- 100
- FWCI
- 51.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.